Inactive Ingredient Search for Approved Drug Products

Search Names Beginning with K

Inactive Ingredient Route Dosage Form CAS Number UNII Maximum Potency per unit dose Maximum Daily Exposure (MDE) Record Updated
KAOLIN ORAL CAPSULE 1332587 24H4NWX5CO NA
KAOLIN ORAL CAPSULE, COATED PELLETS 1332587 24H4NWX5CO 14.61mg
KAOLIN ORAL CAPSULE, EXTENDED RELEASE 1332587 24H4NWX5CO 21mg
KAOLIN ORAL POWDER, FOR SUSPENSION 1332587 24H4NWX5CO NA
KAOLIN ORAL SYRUP 1332587 24H4NWX5CO 10mg/1ml
KAOLIN ORAL TABLET 1332587 24H4NWX5CO 150mg
KAOLIN ORAL TABLET, COATED 1332587 24H4NWX5CO 52.44mg
KAOLIN ORAL TABLET, DELAYED RELEASE 1332587 24H4NWX5CO 18.5mg
KAOLIN ORAL TABLET, EXTENDED RELEASE 1332587 24H4NWX5CO 66mg
KAOLIN ORAL TABLET, SUGAR COATED 1332587 24H4NWX5CO NA
KAOLIN TOPICAL SYSTEM 1332587 24H4NWX5CO 420mg
KARAYA GUM BUCCAL SYSTEM 9000366 73W9IQY50Q 68.1mg
KOLLICOAT SR 30D ORAL TABLET, EXTENDED RELEASE IDP0HWP8PJ 270mg
KOLLICOAT SR 30D ORAL TABLET, FILM COATED, EXTENDED RELEASE IDP0HWP8PJ 22.28mg
KOLLIDON SR ORAL TABLET, EXTENDED RELEASE 264876688 S34RY76LK6 564mg Y

 

 

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: September 30, 2021
Database Last Updated: October 21, 2021

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English